When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Broad Street Realty

The Trade: Broad Street Realty, Inc. BRST Director Samuel M Spiritos acquired a total of 10885 shares at an average price of $2.28. To acquire these shares, it cost $24,831.65.

What’s Happening: The company’s stock surged over 30% over the previous month.

What Broad Street Realty Does: Broad Street Realty Inc is a fully integrated real estate company that owns, operates, develops, and redevelops primarily grocery-anchored shopping centers and street retail-based properties in the Mid-Atlantic and Denver, Colorado markets.

Baudax Bio

The Trade: Baudax Bio, Inc. BXRX Director Winston Churchill acquired a total of 100000 shares shares at an average price of $0.63. The insider spent $62,930.00 to buy those shares.

What’s Happening: The company, last month, reported downbeat quarterly results.

What Baudax Bio Does: Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.

Calyxt

The Trade: Calyxt, Inc. CLXT President and CEO Michael A Carr acquired a total of 10000 shares at an average price of $3.98. To acquire these shares, it cost $39,776.00.

What’s Happening: Calyxt, last month, reported better-than-expected quarterly results.

What Calyxt Does: Calyxt Inc is a technology company focused on delivering plant-based innovations and solutions.

ReShape Lifesciences

The Trade: ReShape Lifesciences Inc. RSLS Chief Financial Officer Thomas Stankovich acquired a total of 15000 shares at an average price of $3.43. To acquire these shares, it cost $51,435.00.

What’s Happening: The company recently reported Q2revenue of $3.5 million, up from $1.7 million in the year-ago period.

What ReShape Lifesciences Does: Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.

Amplify Energy

The Trade: Amplify Energy Corp. AMPY Director Evan Lederman acquired a total of 10000 shares at an average price of $3.69. To acquire these shares, it cost $36,900.00.

What’s Happening: The company, last month, reported a narrower quarterly loss.

What Amplify Energy Does: Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation and production of oil and natural gas properties in the United States.